The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harmar, A. J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J. R., Rawlings, S. R., Robberecht, P., Said, S. I., Sreedharan, S. P., et al. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01360-7 · Cited by 765
Reubi, J., Waser, B., Schaer, J.-C., & Laissue, J. A. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100541 · Cited by 657
Self-citationLOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Lameris, J. S., Bakker, W. H., Koper, J. W., Ausema, L., Reubi, J. C., & Lamberts, S. W. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91258-0 · Cited by 625
Self-citationGastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
Markwalder, R. V., & Reubi, J. C. (1999) · PubMed · Cited by 506
Self-citation[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P., Konijnenberg, M. W., Srinivasan, A., Erion, J. L., Schmidt, M. A., Bugaj, J. L., de Jong, M., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100574 · Cited by 471
Gibril, F., Reynolds, J. C., Doppman, J. L., Chen, C. C., Venzon, D. J., Termanini, B., Weber, H. C., Stewart, C. A., & Jensen, R. T. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00005 · Cited by 440
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi, J. C., Schaer, J., & Waser, B. (1997) · PubMed · Cited by 349
Self-citationYttrium-90-labelled somatostatin-analogue for cancer treatment
Otte, A., Mueller-Brand, J., Dellas, S., Nitzsche, E., Herrmann, R., & Maecke, H. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78355-0 · Cited by 335
Wank, S. A. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.5.g628 · Cited by 323
Reubi, J. C., Läderach, U., Waser, B., Gebbers, J.-O., Robberecht, P., & Laissue, J. A. (2000) · PubMed · Cited by 287
Self-citationGlucagonlike peptide 1: a newly discovered gastrointestinal hormone
Holst, J. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90831-1 · Cited by 252
[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging
Nock, B., Nikolopoulou, A., Chiotellis, E., Loudos, G., Maintas, D., Reubi, J., & Maina, T. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1040-x · Cited by 194
Self-citationKroog, G. S., Jensen, R. T., & Battey, J. F. (1995) · Medicinal Research Reviews · doi:10.1002/med.2610150502 · Cited by 166
Reubi, J. C. (1995) · PubMed · Cited by 135
Self-citationSomatostatin receptors in human prostate and prostate cancer
Reubi, J. C., Waser, B., Schaer, J., & Markwalder, R. V. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673428 · Cited by 123
Self-citationNovel analogues of neuropeptide Y with a preference for the Y 1 ‐receptor
Söll, R., Dinger, M. C., Lundell, I., Larhammer, D., & Beck‐Sickinger, A. G. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02161.x · Cited by 103
de Jong, M., Breeman, W. A. P., Bernard, B. F., Bakker, W. H., Visser, T. J., Kooij, P. P. M., van Gameren, A., & Krenning, E. P. (2001) · PubMed · Cited by 102
A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors
Reubi, J. C., Eisenwiener, K., Rink, H., Waser, B., & Mäcke, H. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02651-1 · Cited by 91
Self-citationLebtahi, R., Cloirec, J. L., Houzard, C., Daou, D., Sobhani, I., Sassolas, G., Mignon, M., Bourguet, P., & Guludec, D. L. (2002) · PubMed · Cited by 89
Janson, E., Stridsberg, M., Gobl, A., Westlin, J.-E., & Öberg, K. (1998) · PubMed · Cited by 81
Virgolini, I. J., Raderer, M., Kurtaran, A., Angelberger, P., Yang, Q., Peck‐Radosavljevic, M., Leimer, M., Kaserer, K., Li, S., Kornek, G. V., et al. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00066-2 · Cited by 55
Regulatory peptide receptors: visualization by autoradiography
Palacios, J. M., & Dietl, M. M. (1987) · Cellular and Molecular Life Sciences · doi:10.1007/bf01945352 · Cited by 22
DOTA‐NOC, A high affinity ligand of the somatostatin receptor subtypes 2, 3 and 5 for radiotherapy
Schmitt, J. S., Wild, D., Ginj, M., Reubi, J. C., Waser, B., de Jong, M., Bernard, B. F., Krenning, E. P., & Mäcke, H. R. (2001) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.25804401246 · Cited by 10
Self-citation
Cited by
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
Self-citationOpportunities in somatostatin research: biological, chemical and therapeutic aspects
Weckbecker, G., Lewis, I., Albert, R., Schmid, H. A., Hoyer, D., & Bruns, C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1255 · Cited by 559
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
Korner, M., Stockli, M., Waser, B., & Reubi, J. C. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.038679 · Cited by 477
“Endocrine tumors Pheochromocytomas 12/20 (60) 3,970 6 1,002 Paragangliomas 5/18 (28) 1,353 6 601 Medullary thyroid carcinomas 5/18 (28) 1,326 6 264 Adrenal cortical adenomas 0/7 (0) Parathyroid carcinomas 0/4 (0) Pituitary adenomas 0/38 (0) Tumors of nervous system Meningiomas 7/20 (35) 989 6 271 Astrocytomas 4/16 (25…”
BackgroundMethodInfluentialSelf-citationKayani, I., Bomanji, J. B., Groves, A., Conway, G., Gacinovic, S., Win, T., Dickson, J., Caplin, M., & Ell, P. J. (2008) · Cancer · doi:10.1002/cncr.23469 · Cited by 477
Cholecystokinin and Gastrin Receptors
Dufresne, M., Seva, C., & Fourmy, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00014.2005 · Cited by 476
Metadata
- Authors
- Reubi, J. C., & Waser, B.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2003-04-18
- Volume
- 30
- Issue
- 5
- Pages
- 781-793
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2080916065
- Cited by
- 592
- References
- 23
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.